<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:obo="http://purl.obolibrary.org/obo/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>ANTIMICROBIAL AGENTS CHEMOTHERAPY, Feb. 2009, p. 525 8211;530                                                                  Vol. 53,  2 <br /> 0066-4804/09/$08.00 11001;0 doi:10.1128/AAC.00917-08 <br /> Copyright  169; 2009, American Society Microbiology. Rights Reserved. <br />  <br />  <br />  <br />                   Variations Amino Acid Composition Antisense <br />                   Peptide-Phosphorodiamidate Morpholino Oligomer <br />                     Affect Potency Escherichia coli Vitro <br />                                      Vivo 17188; <br />    Brett L. Mellbye,1 Susan E. Puckett,2 Luke D. Tilley,1 Patrick L. Iversen,1 Bruce L. Geller1,2* <br />                                 AVI BioPharma, ,1 Oregon State University,2 Corvallis, Oregon <br />                       Received 10 July 2008/Returned modification 24 September 2008/Accepted 7 November 2008 <br />  <br />              potency antisense peptide-phosphorodiamidate morpholino oligomers (PPMOs) improved           varying peptide composition. antisense phosphorodiamidate morpholino oligomer (PMO) complemen- <br />           tary mRNA essential gene acpP  encodes acyl <span id='am-637' about='obo:IMR_0000920' typeof='owl:Thing obo:IMR_0000949 obo:IMR_0001049 obo:IMR_0000001'><span id='am-638' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-639' property="oboInOwl:id" content="IMR:0000920" datatype="xsd:string"></span><span id='am-640' property="rdfs:label" content="transporter" datatype="xsd:string"></span><span id='am-641' property="oboInOwl:hasExactSynonym" content="permease" datatype="xsd:string"></span><span id='am-642' property="obo:IAO_0000115" content="Binds the specific solute to be transported and undergo a series of conformational changes to transfer the bound solute across the bilayer." datatype="xsd:string"></span><span id='am-643' property="rdfs:label" content="carrier" datatype="xsd:string"></span><span id='am-644' property="oboInOwl:hasExactSynonym" content="carrier" datatype="xsd:string"></span><span id='am-645' property="rdfs:label" content="permease" datatype="xsd:string"></span>carrier</span> <span id='am-602' about='obo:IMR_0000949' typeof='owl:Thing obo:IMR_0000001'><span id='am-603' property="rdfs:label" content="protein" datatype="xsd:string"></span><span id='am-604' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-605' property="oboInOwl:id" content="IMR:0000949" datatype="xsd:string"></span>protein</span> required lipid <br />           biosynthesis) Escherichia coli conjugated 5 11541; ends various cationic membrane-penetrating <br />           peptides. peptide repeating sequence motifs: C-N-N (motif 1), C-N (motif 2), C-N-C <br />           (motif 3), C cationic residue N nonpolar residue. Variations cationic residues included <br />           arginine, lysine, ornithine (O). Variations nonpolar residues included phenylalanine, valine, <br />            65533;? 65533;-alanine (B), 6-aminohexanoic acid (X). MICs PPMOs varied 0.625 &gt;80  65533;? 65533;M            3 480  65533;? 65533;g/ml). potent (RX)6B-, (RXR)4XB-, (RFR)4XB-AcpP PMOs,           tested <span id='am-646' about='obo:IMR_0703999' typeof='owl:Thing'><span id='am-647' property="oboInOwl:hasExactSynonym" content="Caspase-14 subunit p10" datatype="xsd:string"></span><span id='am-648' property="rdfs:label" content="CASPE_HUMAN" datatype="xsd:string"></span><span id='am-649' property="oboInOwl:hasExactSynonym" content="CASP-14" datatype="xsd:string"></span><span id='am-650' property="oboInOwl:hasExactSynonym" content="MGC119078" datatype="xsd:string"></span><span id='am-651' property="rdfs:label" content="CASP-14" datatype="xsd:string"></span><span id='am-652' property="rdfs:label" content="Caspase-14" datatype="xsd:string"></span><span id='am-653' property="oboInOwl:hasExactSynonym" content="EC 3.4.22.-" datatype="xsd:string"></span><span id='am-654' property="rdfs:label" content="MICE" datatype="xsd:string"></span><span id='am-655' property="rdfs:label" content="EC 3.4.22.-" datatype="xsd:string"></span><span id='am-656' property="oboInOwl:hasExactSynonym" content="CASP14" datatype="xsd:string"></span><span id='am-657' property="rdfs:label" content="MGC119079" datatype="xsd:string"></span><span id='am-658' property="oboInOwl:hasExactSynonym" content="caspase 14, apoptosis-related cysteine peptidase" datatype="xsd:string"></span><span id='am-659' property="oboInOwl:hasExactSynonym" content="MICE" datatype="xsd:string"></span><span id='am-660' property="rdfs:label" content="MGC119078" datatype="xsd:string"></span><span id='am-661' property="oboInOwl:hasExactSynonym" content="Caspase-14 subunit p19" datatype="xsd:string"></span><span id='am-662' property="rdfs:label" content="caspase 14, apoptosis-related cysteine peptidase" datatype="xsd:string"></span><span id='am-663' property="rdfs:label" content="Caspase-14 subunit p19" datatype="xsd:string"></span><span id='am-664' property="rdfs:label" content="Caspase-14 subunit p10" datatype="xsd:string"></span><span id='am-665' property="rdfs:label" content="CASP14" datatype="xsd:string"></span><span id='am-666' property="rdfs:label" content="CASPASE 14, APOPTOSIS-RELATED CYSTEINE PROTEASE" datatype="xsd:string"></span><span id='am-667' property="oboInOwl:hasExactSynonym" content="CASPASE 14, APOPTOSIS-RELATED CYSTEINE PROTEASE" datatype="xsd:string"></span><span id='am-668' property="oboInOwl:hasExactSynonym" content="MGC119079" datatype="xsd:string"></span><span id='am-669' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-670' property="oboInOwl:id" content="IMR:0703999" datatype="xsd:string"></span><span id='am-671' property="oboInOwl:hasExactSynonym" content="Caspase-14" datatype="xsd:string"></span><span id='am-672' property="oboInOwl:hasDbXref" content="UniProt:P31944" datatype="xsd:string"></span>mice</span> infected E. coli. (RXR)4XB-AcpP PMO potent           conjugates tested <span id='am-673' about='obo:IMR_0703998' typeof='owl:Thing'><span id='am-674' property="oboInOwl:hasExactSynonym" content="mini-ICE" datatype="xsd:string"></span><span id='am-675' property="oboInOwl:hasExactSynonym" content="Caspase-14 subunit p19" datatype="xsd:string"></span><span id='am-676' property="oboInOwl:hasExactSynonym" content="MICE" datatype="xsd:string"></span><span id='am-677' property="rdfs:label" content="Caspase-14 subunit p10" datatype="xsd:string"></span><span id='am-678' property="rdfs:label" content="MICE" datatype="xsd:string"></span><span id='am-679' property="oboInOwl:hasExactSynonym" content="CASP-14" datatype="xsd:string"></span><span id='am-680' property="oboInOwl:hasDbXref" content="UniProt:O89094" datatype="xsd:string"></span><span id='am-681' property="oboInOwl:hasExactSynonym" content="EC 3.4.22.-" datatype="xsd:string"></span><span id='am-682' property="rdfs:label" content="Caspase-14 subunit p19" datatype="xsd:string"></span><span id='am-683' property="rdfs:label" content="CASP-14" datatype="xsd:string"></span><span id='am-684' property="rdfs:label" content="caspase 14" datatype="xsd:string"></span><span id='am-685' property="rdfs:label" content="EC 3.4.22.-" datatype="xsd:string"></span><span id='am-686' property="rdfs:label" content="Caspase-14" datatype="xsd:string"></span><span id='am-687' property="rdfs:label" content="Casp14" datatype="xsd:string"></span><span id='am-688' property="oboInOwl:hasExactSynonym" content="Casp14" datatype="xsd:string"></span><span id='am-689' property="oboInOwl:hasExactSynonym" content="Mini-ICE" datatype="xsd:string"></span><span id='am-690' property="rdfs:label" content="mini-ICE" datatype="xsd:string"></span><span id='am-691' property="oboInOwl:id" content="IMR:0703998" datatype="xsd:string"></span><span id='am-692' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-693' property="rdfs:label" content="CASPE_MOUSE" datatype="xsd:string"></span><span id='am-694' property="oboInOwl:hasExactSynonym" content="Caspase-14" datatype="xsd:string"></span><span id='am-695' property="oboInOwl:hasExactSynonym" content="caspase 14" datatype="xsd:string"></span><span id='am-696' property="oboInOwl:hasExactSynonym" content="Caspase-14 subunit p10" datatype="xsd:string"></span><span id='am-697' property="rdfs:label" content="Mini-ICE" datatype="xsd:string"></span>mice</span>. administration 30  65533;? 65533;g (1.5 mg/kg body weight) (RXR)4XB-AcpP PMO           15 min postinfection reduced CFU/ml blood 102 103 2 12 h compared numbers           water-treated controls. mice treated 30  65533;? 65533;g/dose (RXR)4XB-AcpP PMO survived infection,           water-treated mice died 12 h postinfection. reduction CFU/ml blood proportional dose <br />           PPMO 30 300  65533;? 65533;g/ml. summary, C-N-C motif effective motifs, <br />           arginine effective lysine ornithine, phenylalanine effective 6-aminohexanoic <br />           acid vitro necessarily vivo, (RXR)4XB-AcpP PMO reduced bacterial infection promoted <br />           survival clinically relevant doses. <br />  <br />  <br />   Antibiotic resistance bacteria, increasing incidence,              conjugated counterparts (7, 10). Apparently, membrane- decreasing rate discovery new antibiotics create            penetrating peptide carries cargo  antisense <br /> need new strategies targeting bacterial components               oligomer) outer membrane gram-negative bac- <br /> antibiotic therapy. Genomics created attractive oppor-               teria, traverses plasma membrane tunity target specific genes inhibition use                unknown mechanism. <br /> antisense oligomers silence essential genes.                                Membrane-penetrating peptides diverse sequences, <br />   Synthetic antisense oligomers DNA mimics bind                    cationic amphipathic. Previous investiga- target RNA complementary <span id='am-395' about='obo:IMR_0100817' typeof='owl:Thing obo:IMR_0000949 obo:IMR_0000001 obo:IMR_0000429 obo:IMR_0000428 obo:IMR_0001014'><span id='am-396' property="rdfs:label" content="base" datatype="xsd:string"></span><span id='am-397' property="oboInOwl:id" content="IMR:0100817" datatype="xsd:string"></span><span id='am-398' property="oboInOwl:hasDbXref" content="GO:0008540" datatype="xsd:string"></span><span id='am-399' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>base</span> pairing.                      tions suggest repeated peptide motif cationic <br /> antisense oligomers added pure bacterial cultures,                   residue followed nonpolar residues shown decrease levels expression                important feature efficient membrane penetration <br /> reporter genes luciferase (5, 7), activate endogenous               (25). <br /> genes  65533;? 65533;-galactosidase (7), inhibit growth tar-                   Antisense oligomers conjugated peptides (KFF)3 <br /> geting essential genes RNA (9, 10, 11, 14, 23, 28).                   (RFF)3 targeted essential gene products potent <br /> addition, antisense oligomers reduce infection increase <br />                                                                             growth inhibitors E. coli, Salmonella enterica serovar Typhi- survival mice infected Escherichia coli (8, 21, <br />                                                                             murium, Staphylococcus aureus, Mycobacterium smegmatis, 22). <br />                                                                             Klebsiella pneumoniae (10, 13, 14, 23). antisense <span id='am-508' about='obo:IMR_0704046' typeof='owl:Thing'><span id='am-509' property="oboInOwl:hasExactSynonym" content="LyP" datatype="xsd:string"></span><span id='am-510' property="oboInOwl:hasExactSynonym" content="Lymphoid phosphatase" datatype="xsd:string"></span><span id='am-511' property="rdfs:label" content="LYP" datatype="xsd:string"></span><span id='am-512' property="rdfs:label" content="PEP" datatype="xsd:string"></span><span id='am-513' property="rdfs:label" content="PTPN8, FORMERLY" datatype="xsd:string"></span><span id='am-514' property="rdfs:label" content="PROTEIN TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 22" datatype="xsd:string"></span><span id='am-515' property="oboInOwl:hasExactSynonym" content="PEP" datatype="xsd:string"></span><span id='am-516' property="rdfs:label" content="Lyp2" datatype="xsd:string"></span><span id='am-517' property="oboInOwl:hasExactSynonym" content="PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE 8, FORMERLY" datatype="xsd:string"></span><span id='am-518' property="rdfs:label" content="PTPN22" datatype="xsd:string"></span><span id='am-519' property="rdfs:label" content="Tyrosine-protein phosphatase non-receptor type 22" datatype="xsd:string"></span><span id='am-520' property="oboInOwl:hasExactSynonym" content="PTPN22" datatype="xsd:string"></span><span id='am-521' property="oboInOwl:hasExactSynonym" content="Hematopoietic cell protein-tyrosine phosphatase 70Z-PEP" datatype="xsd:string"></span><span id='am-522' property="rdfs:label" content="PEST-DOMAIN PHOSPHATASE" datatype="xsd:string"></span><span id='am-523' property="oboInOwl:hasExactSynonym" content="PTPN8" datatype="xsd:string"></span><span id='am-524' property="oboInOwl:hasExactSynonym" content="EC 3.1.3.48" datatype="xsd:string"></span><span id='am-525' property="oboInOwl:hasExactSynonym" content="PROTEIN TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 22" datatype="xsd:string"></span><span id='am-526' property="oboInOwl:hasExactSynonym" content="Lyp2" datatype="xsd:string"></span><span id='am-527' property="oboInOwl:hasExactSynonym" content="Lyp1" datatype="xsd:string"></span><span id='am-528' property="rdfs:label" content="PTPN8" datatype="xsd:string"></span><span id='am-529' property="oboInOwl:id" content="IMR:0704046" datatype="xsd:string"></span><span id='am-530' property="oboInOwl:hasExactSynonym" content="PEST-DOMAIN PHOSPHATASE" datatype="xsd:string"></span><span id='am-531' property="oboInOwl:hasDbXref" content="UniProt:Q9Y2R2" datatype="xsd:string"></span><span id='am-532' property="oboInOwl:hasExactSynonym" content="LYP" datatype="xsd:string"></span><span id='am-533' property="rdfs:label" content="Lyp1" datatype="xsd:string"></span><span id='am-534' property="rdfs:label" content="protein tyrosine phosphatase, non-receptor type 22 (lymphoid)" datatype="xsd:string"></span><span id='am-535' property="oboInOwl:hasExactSynonym" content="LYP2" datatype="xsd:string"></span><span id='am-536' property="oboInOwl:hasExactSynonym" content="PTPN8, FORMERLY" datatype="xsd:string"></span><span id='am-537' property="rdfs:label" content="Lyp" datatype="xsd:string"></span><span id='am-538' property="oboInOwl:hasExactSynonym" content="protein tyrosine phosphatase, non-receptor type 22 (lymphoid)" datatype="xsd:string"></span><span id='am-539' property="rdfs:label" content="PTN22_HUMAN" datatype="xsd:string"></span><span id='am-540' property="rdfs:label" content="LyP" datatype="xsd:string"></span><span id='am-541' property="rdfs:label" content="LYP1" datatype="xsd:string"></span><span id='am-542' property="rdfs:label" content="EC 3.1.3.48" datatype="xsd:string"></span><span id='am-543' property="oboInOwl:hasExactSynonym" content="Lyp" datatype="xsd:string"></span><span id='am-544' property="rdfs:label" content="PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE 8, FORMERLY" datatype="xsd:string"></span><span id='am-545' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-546' property="oboInOwl:hasExactSynonym" content="Tyrosine-protein phosphatase non-receptor type 22" datatype="xsd:string"></span><span id='am-547' property="rdfs:label" content="Lymphoid phosphatase" datatype="xsd:string"></span><span id='am-548' property="rdfs:label" content="LYP2" datatype="xsd:string"></span><span id='am-549' property="rdfs:label" content="Hematopoietic cell protein-tyrosine phosphatase 70Z-PEP" datatype="xsd:string"></span><span id='am-550' property="oboInOwl:hasExactSynonym" content="LYP1" datatype="xsd:string"></span>pep</span>- <br />   Antisense oligomers require assistance gain entry                                                                             tide-oligomers variations peptide sequences bacterial cells molecular weight polar <br />                                                                             screened efficacies gram-positive bacte- <br /> characteristics. Recently, antisense oligomers                                                                             rium S. aureus (17), effects variations conjugated membrane-penetrating peptides. Peptide-oli- <br /> gomer conjugates significantly effective inhibit-               gram-negative bacterium E. coli reported (10, 23). <br /> ing expression specific targets non-                 reports effects                                                                             variations peptide sequences antisense peptide- <br />                                                                             oligomers animal models bacterial infection. <br />   * Corresponding author. Mailing address: Department Microbi-              study described report, E. coli used ology, 220 Nash Hall, Oregon State University, Corvallis, 97331- <br />                                                                             compare efficacies vitro vivo antisense <span id='am-633' about='obo:IMR_0100342' typeof='owl:Thing obo:IMR_0100341 obo:IMR_0000272 obo:IMR_0000949 obo:IMR_0010044 obo:IMR_0000273 obo:IMR_0100337 obo:IMR_0000001 obo:IMR_0000517 obo:IMR_0000207'><span id='am-634' property="oboInOwl:id" content="IMR:0100342" datatype="xsd:string"></span><span id='am-635' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-636' property="rdfs:label" content="PEP" datatype="xsd:string"></span>pep</span>- <br /> 3804. Phone: (541) 737-1845. Fax: (541) 737-0496. E-mail: gellerb <br /> @orst.edu.                                                                  tide-phosphorodiamidate morpholino oligomers (PPMOs) <br />    17188; <br />     Published ahead print 17 November 2008.                           vary amino acid sequences. <br />  <br />                                                                       525 <br />  526       MELLBYE ET AL.                                                                                                         ANTIMICROB. AGENTS CHEMOTHER. <br />  <br />                         MATERIALS METHODS                                              TABLE 1. MICs peptide-AcpP11 PMO conjugates pure <br />    Bacterial strains. Wild-type strain E. coli K-12 W3110 used exper-                             cultures E. coli <br /> iments. Liquid cultures grown Mueller-Hinton II broth  MIC                                                                                 MIC <br /> assays) LB broth  preparation inoculum mice).                       Motif PMO                   Conjugated peptide <br />    MICs. MICs determined microdilution method (4). control                                                                            65533;? 65533;M           65533;? 65533;g/ml <br /> nonspecific toxicity, peptide conjugated second phosphoro- <br /> diamidate morpholino oligomer (PMO) base sequence                Motif 1 (C-N-N) <br /> complementary gene E. coli. cases, MIC control PPMO       05-0198                      RFFXB                               11022;80        11022;360 limit measurement, 80  65533;? 65533;M.                                  05-0197                      RFFRFFXB                            20         99 <br />    PMO. PPMOs synthesized AVI BioPharma (Corvallis,                  05-0200                      RFFRFFRFFRXB                         2.5       14 <br /> scribed previously (23). base sequence AcpP PMO 5 11032;-CTTCGAT              05-0653                      DRFDFDRDFDFDRDFDFD                   5         28 <br /> AGTG-3 11032;, complementary bases 1153197 1153207 E. coli                                           RXBa <br /> W3110 genomic <span id='am-489' about='obo:IMR_0002304' typeof='owl:Thing'><span id='am-490' property="oboInOwl:hasDbXref" content="UniProt:P12872" datatype="xsd:string"></span><span id='am-491' property="oboInOwl:hasExactSynonym" content="MAP" datatype="xsd:string"></span><span id='am-492' property="oboInOwl:hasExactSynonym" content="motilin" datatype="xsd:string"></span><span id='am-493' property="oboInOwl:hasExactSynonym" content="Promotilin" datatype="xsd:string"></span><span id='am-494' property="oboInOwl:hasExactSynonym" content="Motilin-associated peptide" datatype="xsd:string"></span><span id='am-495' property="rdfs:label" content="MLN" datatype="xsd:string"></span><span id='am-496' property="oboInOwl:hasExactSynonym" content="MGC138519" datatype="xsd:string"></span><span id='am-497' property="rdfs:label" content="Promotilin" datatype="xsd:string"></span><span id='am-498' property="rdfs:label" content="MOTI_HUMAN" datatype="xsd:string"></span><span id='am-499' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-500' property="rdfs:label" content="Motilin" datatype="xsd:string"></span><span id='am-501' property="rdfs:label" content="MGC138519" datatype="xsd:string"></span><span id='am-502' property="rdfs:label" content="MAP" datatype="xsd:string"></span><span id='am-503' property="oboInOwl:hasExactSynonym" content="MLN" datatype="xsd:string"></span><span id='am-504' property="oboInOwl:hasExactSynonym" content="Motilin" datatype="xsd:string"></span><span id='am-505' property="oboInOwl:id" content="IMR:0002304" datatype="xsd:string"></span><span id='am-506' property="rdfs:label" content="Motilin-associated peptide" datatype="xsd:string"></span><span id='am-507' property="rdfs:label" content="motilin" datatype="xsd:string"></span>map</span> (NCBI accession number AP009048). target sequence                23-248                      RXXRXXRXXB                          20        102 immediately 3 11032; start codon. rationale length position     06-0199                     KFFKFFKFFKXB                        10         54 PMO target mRNA characterized previously (5). PMO             06-0064                     RBBRBBRBBRXB                        11022;80        11022;408 <br /> sequence shown inhibit growth E. coli pure cultures (5, 8,       06-0079                     RVVRVVRVVRXB                        11022;80        11022;422 <br /> 23), infected tissue culture (23), mouse models infection (8, 22). base     06-0082                     OFFOFFOFFOXB                        11022;80        11022;431 <br /> sequence nonsensical control PMOs 5 11032;-TCTCAGATGGT-3 11032;. non- <br /> sensical (scrambled) sequence random sequence 11 bases used         Motif 2 (C-N) AcpP PMO previously shown inhibit growth E.         06-0067                      RXRXB                               11022;80        11022;358 <br /> coli (5, 8, 23, 24).                                                                  06-0070                      RXRXRXRXB                           80        401 <br />    Mouse experiments. mice infected treated PPMOs            06-0073                      RXRXRXRXRXRXB                        1.25       6.9 <br /> described previously (22). Briefly, groups mice infected     06-0761                      KXKXKXKXKXKXB                       11022;80        11022;430 intraperitoneal injection E. coli W3110. mice treated intra-       06-0762                      OXOXOXOXOXOXB                       11022;80        11022;424 <br /> peritoneal injection 15 min 12 h postinfection. Blood collected 2, <br /> 6, 12, 24, 48 h postinfection; diluted; plated determine numbers      Motif 3 (C-N-C) viable bacteria.                                                                   06-0076                      RXRRXRRXRRXRXB                       1.25          7.2 <br />    animal procedures approved Oregon State University Animal          06-0824                      KXKKXKKXKKXKXB                      20           111 <br /> Care Use Committee complied state federal laws.                  06-0763                      OXOOXOOXOOXOXB                      10            54 <br />    Statistical analysis. mean numbers CFU/ml blood standard devi-          07-0795                      RFRRFRRFRRFRXB                       0.625         3.7 <br /> ation calculated treatment group using Prism (version 4.0)           07-1119                      RXRRBRRXRRBRXB                       2.5          14 <br /> software (GraphPad Software, San Diego, CA). Survival curves analyzed Kaplan-Meier method Prism (version 4.0) software. Group means          Control (ampicillin)                                               6.7            2.5 <br /> compared transforming numbers CFU/ml log CFU/ml using                                                                                                       D,   residue follows D-isomeric form. way analysis variance, parametric methods, Kolmogorov Smirnov <br /> normality test, Tukey-Kramer multiple comparison post test (InStat, <br /> version 3.05, software; GraphPad Software). <br />  <br />  <br />                                                                                      form (RFF)3RXB (PPMO 05-0653) MIC                                   RESULTS                                            times higher equivalent L-isomeric <br />    Efficacies various PPMOs pure culture. Various                              form (PPMO 05-0200). <br /> PPMOs synthesized base sequence targeting                            MIC PPMO motif 2 (C-N) motif 3 region near start codon mRNA acpP,                          (C-N-C) measured. PPMOs (RX)6B, (RXR)4XB, different peptides attached 5 11032; end (Table 1). pep-                       (RFR)4XB potent PPMOs (RXX)3B tide designed repeated sequence motifs:                        (RFF)3RXB. substitution lysine ornithine   C-N-N (motif 1), (ii) C-N (motif 2), (iii) C-N-C (motif 3),                   arginine PPMOs motif 2 3 reduced potency. C cationic residue N nonpolar residue.                       tandem copies RX potent tandem <br /> cationic amino acids used arginine, lysine,                       copies RX. <br /> ornithine (O); nonpolar amino acids used                              Mouse peritonitis. (RX)6B-AcpP PMO, (RXR)4XB- phenylalanine, valine,  65533;? 65533;-alanine (B), 6-aminohex-                           AcpP PMO, (RFR)4XB-AcpP PMO tested mice <br /> anoic acid (X).                                                                      infected E. coli. Groups mice treated various <br />    MIC PPMO motif 1 (C-N-N) mea-                                doses PPMOs ranging 10 300  65533;? 65533;<span id='am-97' about='obo:IMR_0702595' typeof='owl:Thing'><span id='am-98' property="rdfs:label" content="1-AGPAT 1" datatype="xsd:string"></span><span id='am-99' property="oboInOwl:hasExactSynonym" content="LPAATA" datatype="xsd:string"></span><span id='am-100' property="rdfs:label" content="MGC5423" datatype="xsd:string"></span><span id='am-101' property="rdfs:label" content="AGPAT1" datatype="xsd:string"></span><span id='am-102' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-103' property="oboInOwl:hasExactSynonym" content="1-AGPAT 1" datatype="xsd:string"></span><span id='am-104' property="oboInOwl:hasExactSynonym" content="MGC5423" datatype="xsd:string"></span><span id='am-105' property="oboInOwl:hasExactSynonym" content="1-acyl-sn-glycerol-3-phosphate acyltransferase alpha" datatype="xsd:string"></span><span id='am-106' property="rdfs:label" content="LPAATA" datatype="xsd:string"></span><span id='am-107' property="oboInOwl:hasExactSynonym" content="AGPAT1" datatype="xsd:string"></span><span id='am-108' property="rdfs:label" content="1-acyl-sn-glycerol-3-phosphate acyltransferase alpha" datatype="xsd:string"></span><span id='am-109' property="oboInOwl:id" content="IMR:0702595" datatype="xsd:string"></span><span id='am-110' property="oboInOwl:hasExactSynonym" content="1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)" datatype="xsd:string"></span><span id='am-111' property="rdfs:label" content="LYSOPHOSPHATIDIC ACID ACYLTRANSFERASE-ALPHA" datatype="xsd:string"></span><span id='am-112' property="rdfs:label" content="1-acylglycerol-3-phosphate O-acyltransferase 1" datatype="xsd:string"></span><span id='am-113' property="rdfs:label" content="1-AGPAT1" datatype="xsd:string"></span><span id='am-114' property="rdfs:label" content="1-AGP acyltransferase 1" datatype="xsd:string"></span><span id='am-115' property="oboInOwl:hasExactSynonym" content="G15" datatype="xsd:string"></span><span id='am-116' property="rdfs:label" content="Protein G15" datatype="xsd:string"></span><span id='am-117' property="oboInOwl:hasExactSynonym" content="LPAAT-alpha" datatype="xsd:string"></span><span id='am-118' property="rdfs:label" content="MGC4007" datatype="xsd:string"></span><span id='am-119' property="rdfs:label" content="Lysophosphatidic acid acyltransferase alpha" datatype="xsd:string"></span><span id='am-120' property="oboInOwl:hasExactSynonym" content="EC 2.3.1.51" datatype="xsd:string"></span><span id='am-121' property="rdfs:label" content="LPAAT-alpha" datatype="xsd:string"></span><span id='am-122' property="oboInOwl:hasExactSynonym" content="1-acylglycerol-3-phosphate O-acyltransferase 1" datatype="xsd:string"></span><span id='am-123' property="rdfs:label" content="1-@ACYLGLYCEROL-3-PHOSPHATE O-ACYLTRANSFERASE 1" datatype="xsd:string"></span><span id='am-124' property="oboInOwl:hasExactSynonym" content="1-@ACYLGLYCEROL-3-PHOSPHATE O-ACYLTRANSFERASE 1" datatype="xsd:string"></span><span id='am-125' property="rdfs:label" content="G15" datatype="xsd:string"></span><span id='am-126' property="oboInOwl:hasExactSynonym" content="Protein G15" datatype="xsd:string"></span><span id='am-127' property="oboInOwl:hasExactSynonym" content="1-AGP acyltransferase 1" datatype="xsd:string"></span><span id='am-128' property="oboInOwl:hasExactSynonym" content="MGC4007" datatype="xsd:string"></span><span id='am-129' property="rdfs:label" content="EC 2.3.1.51" datatype="xsd:string"></span><span id='am-130' property="oboInOwl:hasExactSynonym" content="Lysophosphatidic acid acyltransferase alpha" datatype="xsd:string"></span><span id='am-131' property="oboInOwl:hasExactSynonym" content="1-AGPAT1" datatype="xsd:string"></span><span id='am-132' property="rdfs:label" content="PLCA_HUMAN" datatype="xsd:string"></span><span id='am-133' property="oboInOwl:hasExactSynonym" content="LYSOPHOSPHATIDIC ACID ACYLTRANSFERASE-ALPHA" datatype="xsd:string"></span><span id='am-134' property="oboInOwl:hasDbXref" content="UniProt:Q99943" datatype="xsd:string"></span><span id='am-135' property="rdfs:label" content="1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha)" datatype="xsd:string"></span>g 15</span> min 12 h <br /> sured shown Table 1. Control PPMOs                           postinfection. <br /> peptides attached PMO complementary se-                                  results (RXR)4XB-AcpP PMO quence MICs 80  65533;? 65533;M (data shown). results                            potent PPMOs tested mice (compare <br /> indicate potent PPMO peptide motif 1                          effects 30- 65533;? 65533;g dose PPMO shown Fig. 1A, <br /> (RFF)3RXB, 2.5 times potent                                B, E, F, G, H). 30- 65533;? 65533;g dose (1.5 mg/kg body weight) <br /> ampicillin molar basis. Furthermore, increasing num-                        (RXR)4XB-AcpP PMO significantly (P  65533;? 0.001)  <br /> ber RFF repeat units reduced MIC                            duced levels bacteria blood 98% 2 h <br />  11022;32-<span id='am-370' about='obo:IMR_0703347' typeof='owl:Thing'><span id='am-371' property="oboInOwl:hasExactSynonym" content="EC 6.3.4.5" datatype="xsd:string"></span><span id='am-372' property="oboInOwl:hasExactSynonym" content="Ass1" datatype="xsd:string"></span><span id='am-373' property="rdfs:label" content="Ass1" datatype="xsd:string"></span><span id='am-374' property="rdfs:label" content="Ass-1" datatype="xsd:string"></span><span id='am-375' property="rdfs:label" content="Citrulline--aspartate ligase" datatype="xsd:string"></span><span id='am-376' property="oboInOwl:hasExactSynonym" content="Citrulline--aspartate ligase" datatype="xsd:string"></span><span id='am-377' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-378' property="oboInOwl:id" content="IMR:0703347" datatype="xsd:string"></span><span id='am-379' property="rdfs:label" content="EC 6.3.4.5" datatype="xsd:string"></span><span id='am-380' property="rdfs:label" content="fold" datatype="xsd:string"></span><span id='am-381' property="oboInOwl:hasExactSynonym" content="Argininosuccinate synthase" datatype="xsd:string"></span><span id='am-382' property="rdfs:label" content="ASSY_MOUSE" datatype="xsd:string"></span><span id='am-383' property="oboInOwl:hasExactSynonym" content="argininosuccinate synthetase 1" datatype="xsd:string"></span><span id='am-384' property="rdfs:label" content="Argininosuccinate synthase" datatype="xsd:string"></span><span id='am-385' property="oboInOwl:hasExactSynonym" content="fold" datatype="xsd:string"></span><span id='am-386' property="oboInOwl:hasExactSynonym" content="Ass-1" datatype="xsd:string"></span><span id='am-387' property="oboInOwl:hasDbXref" content="UniProt:P16460" datatype="xsd:string"></span><span id='am-388' property="rdfs:label" content="argininosuccinate synthetase 1" datatype="xsd:string"></span>fold</span>  11022;80 2.5  65533;? 65533;M. replacement arginine                             compared levels water- scrambled-sequence- lysine ornithine increased <span id='am-28' about='obo:IMR_0701479' typeof='owl:Thing'><span id='am-29' property="rdfs:label" content="CD44R" datatype="xsd:string"></span><span id='am-30' property="oboInOwl:hasExactSynonym" content="Phagocytic glycoprotein I" datatype="xsd:string"></span><span id='am-31' property="rdfs:label" content="MDU3" datatype="xsd:string"></span><span id='am-32' property="rdfs:label" content="PGP-I" datatype="xsd:string"></span><span id='am-33' property="oboInOwl:hasExactSynonym" content="Pgp1" datatype="xsd:string"></span><span id='am-34' property="rdfs:label" content="Phagocytic glycoprotein I" datatype="xsd:string"></span><span id='am-35' property="rdfs:label" content="HCELL" datatype="xsd:string"></span><span id='am-36' property="rdfs:label" content="CDw44" datatype="xsd:string"></span><span id='am-37' property="oboInOwl:hasExactSynonym" content="MIC4" datatype="xsd:string"></span><span id='am-38' property="oboInOwl:hasExactSynonym" content="GP90 lymphocyte homing/adhesion receptor" datatype="xsd:string"></span><span id='am-39' property="oboInOwl:hasExactSynonym" content="Extracellular matrix receptor III" datatype="xsd:string"></span><span id='am-40' property="rdfs:label" content="MIC4" datatype="xsd:string"></span><span id='am-41' property="oboInOwl:id" content="IMR:0701479" datatype="xsd:string"></span><span id='am-42' property="oboInOwl:hasExactSynonym" content="ECMR-III" datatype="xsd:string"></span><span id='am-43' property="rdfs:label" content="CSPG8" datatype="xsd:string"></span><span id='am-44' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-45' property="rdfs:label" content="ECMR-III" datatype="xsd:string"></span><span id='am-46' property="oboInOwl:hasExactSynonym" content="MC56" datatype="xsd:string"></span><span id='am-47' property="rdfs:label" content="Hyaluronate receptor" datatype="xsd:string"></span><span id='am-48' property="oboInOwl:hasExactSynonym" content="CD44" datatype="xsd:string"></span><span id='am-49' property="oboInOwl:hasExactSynonym" content="MGC10468" datatype="xsd:string"></span><span id='am-50' property="rdfs:label" content="CD44 antigen" datatype="xsd:string"></span><span id='am-51' property="rdfs:label" content="Heparan sulfate proteoglycan" datatype="xsd:string"></span><span id='am-52' property="oboInOwl:hasExactSynonym" content="LHR" datatype="xsd:string"></span><span id='am-53' property="oboInOwl:hasExactSynonym" content="CD44R" datatype="xsd:string"></span><span id='am-54' property="oboInOwl:hasExactSynonym" content="HUTCH-I" datatype="xsd:string"></span><span id='am-55' property="oboInOwl:hasExactSynonym" content="PGP-1" datatype="xsd:string"></span><span id='am-56' property="rdfs:label" content="Hermes antigen" datatype="xsd:string"></span><span id='am-57' property="rdfs:label" content="LHR" datatype="xsd:string"></span><span id='am-58' property="rdfs:label" content="INLU-RELATED p80 GLYCOPROTEIN" datatype="xsd:string"></span><span id='am-59' property="oboInOwl:hasExactSynonym" content="CD44 antigen" datatype="xsd:string"></span><span id='am-60' property="oboInOwl:hasExactSynonym" content="CD44 molecule (Indian blood group)" datatype="xsd:string"></span><span id='am-61' property="rdfs:label" content="MDU2" datatype="xsd:string"></span><span id='am-62' property="rdfs:label" content="Pgp1" datatype="xsd:string"></span><span id='am-63' property="rdfs:label" content="MC56" datatype="xsd:string"></span><span id='am-64' property="oboInOwl:hasDbXref" content="UniProt:P16070" datatype="xsd:string"></span><span id='am-65' property="rdfs:label" content="MGC10468" datatype="xsd:string"></span><span id='am-66' property="rdfs:label" content="CDW44" datatype="xsd:string"></span><span id='am-67' property="oboInOwl:hasExactSynonym" content="Phagocytic glycoprotein 1" datatype="xsd:string"></span><span id='am-68' property="oboInOwl:hasExactSynonym" content="INLU-RELATED p80 GLYCOPROTEIN" datatype="xsd:string"></span><span id='am-69' property="rdfs:label" content="Extracellular matrix receptor III" datatype="xsd:string"></span><span id='am-70' property="oboInOwl:hasExactSynonym" content="HCELL" datatype="xsd:string"></span><span id='am-71' property="oboInOwl:hasExactSynonym" content="CDW44" datatype="xsd:string"></span><span id='am-72' property="rdfs:label" content="CD44" datatype="xsd:string"></span><span id='am-73' property="rdfs:label" content="Phagocytic glycoprotein 1" datatype="xsd:string"></span><span id='am-74' property="oboInOwl:hasExactSynonym" content="Hermes antigen" datatype="xsd:string"></span><span id='am-75' property="rdfs:label" content="GP90 lymphocyte homing/adhesion receptor" datatype="xsd:string"></span><span id='am-76' property="oboInOwl:hasExactSynonym" content="Hyaluronate receptor" datatype="xsd:string"></span><span id='am-77' property="rdfs:label" content="CD44_HUMAN" datatype="xsd:string"></span><span id='am-78' property="oboInOwl:hasExactSynonym" content="CSPG8" datatype="xsd:string"></span><span id='am-79' property="rdfs:label" content="PGP-1" datatype="xsd:string"></span><span id='am-80' property="oboInOwl:hasExactSynonym" content="MDU2" datatype="xsd:string"></span><span id='am-81' property="oboInOwl:hasExactSynonym" content="Heparan sulfate proteoglycan" datatype="xsd:string"></span><span id='am-82' property="rdfs:label" content="CD44 molecule (Indian blood group)" datatype="xsd:string"></span><span id='am-83' property="oboInOwl:hasExactSynonym" content="MDU3" datatype="xsd:string"></span><span id='am-84' property="oboInOwl:hasExactSynonym" content="PGP-I" datatype="xsd:string"></span><span id='am-85' property="oboInOwl:hasExactSynonym" content="CDw44" datatype="xsd:string"></span><span id='am-86' property="rdfs:label" content="HUTCH-I" datatype="xsd:string"></span><span id='am-87' property="rdfs:label" content="Epican" datatype="xsd:string"></span><span id='am-88' property="oboInOwl:hasExactSynonym" content="Epican" datatype="xsd:string"></span>MIC 4</span>-fold                             PPMO-treated controls. Higher doses (100  65533;? 65533;g 300  65533;? 65533;g)  11022;32-fold, respectively. substitution valine,  65533;? 65533;-alanine,                       (RXR)4XB-AcpP PMO reduced CFU/ml 6-aminohexanoic acid phenylalanine increased                              blood proportionally 2.5 4 orders magnitude <br /> MICs eightfold (compare MICs PPMOs 06-                               12 h posttreatment. mice treated 0079, 06-0064, 23-248 MIC PPMO 05-0200                               30- 65533;? 65533;g, 100- 65533;? 65533;g, 300- 65533;? 65533;g dose survived infection. Table 1). Interestingly, PPMO D-isomeric                             significant difference (P  11022; 0.05) rates survival <br />  VOL. 53, 2009                                                                         ANTISENSE MORPHOLINO POTENCY                 527 <br />  <br />  <br />  <br />  <br />   FIG. 1. Bacteria blood survival mice. Groups mice (n  11005; 3 7) infected E. coli treated 15 min 12 h <br /> postinfection (arrows) various PPMOs, scrambled-base-sequence (Scr) (RXR)4XB PPMO, ampicillin. Blood collected indicated times spread LB plates determine numbers CFU.  B) (RXR)4XB-PMO; (C D) ampicillin; (E F) <br /> (RX)6B-PMO; (G H) (RFR)4XB-PMO. Error bars indicate standard deviations. <br />  <br />  <br />  group treated water treated 10        B). 30- 65533;? 65533;g dose (RX)6B-AcpP PMO signifi- <br />  65533;? 65533;g.                                                                  cantly (P  65533;? 0.001) reduced CFU/ml blood 88% 2 h <br />    Groups mice treated 30- 65533;? 65533;g, 100- 65533;? 65533;g, 300- 65533;? 65533;g       postinfection. 100- 65533;? 65533;g 300- 65533;? 65533;g doses significantly <br /> dose ampicillin comparison results ob-        (P  65533;? 0.001) reduced CFU/ml blood equally 3 <br /> tained mice treated PPMO (Fig. 1C D). Thirty-         orders magnitude times postinfection. mice treated <br /> microgram doses ampicillin ineffective reducing           100  65533;? 65533;g/dose (RX)6B-AcpP PMO survived, sig- <br /> CFU/ml blood increasing rate survival.      nificant numbers mice did survive treatment 10  65533;? 65533;g, higher doses ampicillin significantly (P  65533;? 0.001) reduced     30  65533;? 65533;g, 300  65533;? 65533;g dose. <br /> CFU/ml blood 3 3.5 orders magnitude           (RFR)4XB-AcpP PMO significantly reduced increased rate survival 100% 48 h.                   numbers bacteria blood promoted survival (Fig. <br />    (RX)6B-AcpP PMO significantly reduced CFU/ml               1G H). Doses 10  65533;? 65533;g 30  65533;? 65533;g did significantly (P  11022; <br /> blood (Fig. 1E F), potent          0.05) reduce CFU/ml blood time. Doses 100  65533;? 65533;g <br /> (RXR)4XB-AcpP PMO (compare Fig. 1E F Fig. 1A                300  65533;? 65533;g significantly (P  65533;? 0.01  65533;? 0.001, respectively) <br />  528     MELLBYE ET AL.                                                                               ANTIMICROB. AGENTS CHEMOTHER. <br />  <br />  <br /> reduced CFU/ml blood 2 h posttreatment.            PPMOs amino acid sequence repeat similar CFU/ml blood reduced proportionally dose,          (RFF)3RXB-AcpP (repeat motif 1; Table 1), arginine supe- 300- 65533;? 65533;g dose showed reduction (2 3 orders          rior lysine ornithine phenylalanine superior magnitude) 2, 6, 12 h postinfection. number            valine,  65533;? 65533;-alanine, 6-aminohexanoic acid. PPMOs <br /> surviving mice proportional dose.                         repeat motifs 2 3, trends similar                                                                      motif 1, valine  65533;? 65533;-alanine evaluated                          DISCUSSION                                  substitutes nonpolar residues. Unfortunately, attempts                                                                      synthesize (RF)6XB-AcpP PMO unsuccessful  <br />    purpose experiments increase po-            cause insoluble aqueous solution. effects tency antisense PPMOs targeted essential gene              observed antimicrobial peptides (18, 26). acpP, previously shown inhibit growth E.         role cationic chains make initial electrostatic <br /> coli pure culture infected mice (22).              contact anionic moieties lipids (3, 29), results <br /> hypothesized efficacies PPMOs increase          consistent suggestion dispersed <br /> varying order cationic nonpolar amino acid res-           positive charge guanidinium group arginine elec- <br /> idues repeating motif replacing arginine            trostatically interact anionic moieties lipids cationic amino acids, phenylalanine            productive manner lysine ornithine (18, <br /> nonpolar amino acids, naturally occurring amino acids             26). superior effect phenylalanine thought nonprotein amino acids. rationale including             attributable bulkiness (19, 20). <br /> nonprotein amino acids peptide moiety pro-              interesting result D-isomers place teolytic degradation reduced.                               L-isomers arginine phenylalanine increased MIC    Previously, Vaara Porro (25) suggested possibility        factor 2. suggests mechanism entry repeating amino acid sequence motifs (cationic-hydro-       PPMOs outer membrane E. coli <span id='am-198' about='obo:IMR_0000054' typeof='owl:Thing obo:IMR_0000949 obo:IMR_0000001'><span id='am-199' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-200' property="oboInOwl:id" content="IMR:0000054" datatype="xsd:string"></span><span id='am-201' property="oboInOwl:hasDbXref" content="GO:0004872" datatype="xsd:string"></span><span id='am-202' property="obo:IAO_0000115" content="Combining with an extracellular or intracellular messenger to initiate a change in cell activity." datatype="xsd:string"></span><span id='am-203' property="rdfs:label" content="receptor" datatype="xsd:string"></span>receptor</span> <br /> phobic-hydrophobic) (cationic-hydrophobic) influ-          mediated. result consistent previous results ence membrane-penetrating characteristics peptides.           models predicted cationic amphipathic results suggest motif effective        peptides penetrate directly membrane lipids (6, 16, motif disorganizing outer membrane         29, 30). <br /> gram-negative bacteria. experiments used com-            (RX)6B-, (RXR)4XB-, (RFR)4XB-AcpP PMOs <br /> pletely different end <span id='am-703' about='obo:IMR_0002979' typeof='owl:Thing'><span id='am-704' property="oboInOwl:hasExactSynonym" content="E(E2F)3D" datatype="xsd:string"></span><span id='am-705' property="oboInOwl:hasExactSynonym" content="pointed" datatype="xsd:string"></span><span id='am-706' property="oboInOwl:hasExactSynonym" content="0998/12" datatype="xsd:string"></span><span id='am-707' property="rdfs:label" content="PNTP1" datatype="xsd:string"></span><span id='am-708' property="rdfs:label" content="pointed-P1" datatype="xsd:string"></span><span id='am-709' property="oboInOwl:hasExactSynonym" content="Ets at 58AB" datatype="xsd:string"></span><span id='am-710' property="rdfs:label" content="Ets94F" datatype="xsd:string"></span><span id='am-711' property="rdfs:label" content="D-ets-2" datatype="xsd:string"></span><span id='am-712' property="oboInOwl:hasExactSynonym" content="Ets2" datatype="xsd:string"></span><span id='am-713' property="rdfs:label" content="CG17077" datatype="xsd:string"></span><span id='am-714' property="rdfs:label" content="E(E2F)3D" datatype="xsd:string"></span><span id='am-715' property="rdfs:label" content="0608/07" datatype="xsd:string"></span><span id='am-716' property="oboInOwl:id" content="IMR:0002979" datatype="xsd:string"></span><span id='am-717' property="oboInOwl:hasExactSynonym" content="3520" datatype="xsd:string"></span><span id='am-718' property="obo:IAO_0000115" content="pnt gene transcription generates alternatively spliced mRNA isoforms that encode two proteins, PntP1 and PntP2.
PntP2 is the homolog of the human Ets-1 transcription factor and functions as a transcriptional activator when phosphorylated by MAPK." datatype="xsd:string"></span><span id='am-719' property="oboInOwl:hasExactSynonym" content="D-ets-2" datatype="xsd:string"></span><span id='am-720' property="oboInOwl:hasExactSynonym" content="PNTP1" datatype="xsd:string"></span><span id='am-721' property="oboInOwl:hasDbXref" content="UniProt:P51023" datatype="xsd:string"></span><span id='am-722' property="rdfs:label" content="Ets at 58AB" datatype="xsd:string"></span><span id='am-723' property="oboInOwl:hasExactSynonym" content="PNTP2" datatype="xsd:string"></span><span id='am-724' property="rdfs:label" content="pointedP2" datatype="xsd:string"></span><span id='am-725' property="oboInOwl:hasExactSynonym" content="0123/09" datatype="xsd:string"></span><span id='am-726' property="rdfs:label" content="0123/09" datatype="xsd:string"></span><span id='am-727' property="rdfs:label" content="EY3-1" datatype="xsd:string"></span><span id='am-728' property="oboInOwl:hasExactSynonym" content="Ets94F" datatype="xsd:string"></span><span id='am-729' property="oboInOwl:hasExactSynonym" content="pointed-RC" datatype="xsd:string"></span><span id='am-730' property="rdfs:label" content="Ets2" datatype="xsd:string"></span><span id='am-731' property="oboInOwl:hasExactSynonym" content="l(3)07825" datatype="xsd:string"></span><span id='am-732' property="rdfs:label" content="Ets58AB" datatype="xsd:string"></span><span id='am-733' property="oboInOwl:hasExactSynonym" content="D-ETS-2" datatype="xsd:string"></span><span id='am-734' property="oboInOwl:hasExactSynonym" content="pointed-P2" datatype="xsd:string"></span><span id='am-735' property="oboInOwl:hasExactSynonym" content="pointedP2" datatype="xsd:string"></span><span id='am-736' property="rdfs:label" content="3520" datatype="xsd:string"></span><span id='am-737' property="oboInOwl:hasExactSynonym" content="DMPOINT1A" datatype="xsd:string"></span><span id='am-738' property="rdfs:label" content="DMPOINT1A" datatype="xsd:string"></span><span id='am-739' property="rdfs:label" content="ets94F" datatype="xsd:string"></span><span id='am-740' property="rdfs:label" content="D-ETS-2" datatype="xsd:string"></span><span id='am-741' property="rdfs:label" content="pointed-P2" datatype="xsd:string"></span><span id='am-742' property="oboInOwl:hasExactSynonym" content="l(3)j1B7" datatype="xsd:string"></span><span id='am-743' property="rdfs:label" content="Ets protein Pointed P2" datatype="xsd:string"></span><span id='am-744' property="rdfs:label" content="PNT2_DROME" datatype="xsd:string"></span><span id='am-745' property="oboInOwl:hasExactSynonym" content="ETS2" datatype="xsd:string"></span><span id='am-746' property="oboInOwl:hasExactSynonym" content="0608/07" datatype="xsd:string"></span><span id='am-747' property="rdfs:label" content="ETS2" datatype="xsd:string"></span><span id='am-748' property="rdfs:label" content="pnt" datatype="xsd:string"></span><span id='am-749' property="rdfs:label" content="D-Ets-2" datatype="xsd:string"></span><span id='am-750' property="oboInOwl:hasExactSynonym" content="ets94F" datatype="xsd:string"></span><span id='am-751' property="rdfs:label" content="EK3-2" datatype="xsd:string"></span><span id='am-752' property="oboInOwl:hasExactSynonym" content="pnt" datatype="xsd:string"></span><span id='am-753' property="rdfs:label" content="pointed-RC" datatype="xsd:string"></span><span id='am-754' property="oboInOwl:hasExactSynonym" content="CG17077" datatype="xsd:string"></span><span id='am-755' property="rdfs:label" content="PNTP2" datatype="xsd:string"></span><span id='am-756' property="oboInOwl:hasExactSynonym" content="ptd" datatype="xsd:string"></span><span id='am-757' property="rdfs:label" content="ETS-like protein pointed, isoform P2/D" datatype="xsd:string"></span><span id='am-758' property="oboInOwl:hasExactSynonym" content="pointed-P1" datatype="xsd:string"></span><span id='am-759' property="rdfs:label" content="l(3)07825" datatype="xsd:string"></span><span id='am-760' property="rdfs:label" content="POINT" datatype="xsd:string"></span><span id='am-761' property="rdfs:label" content="pointed" datatype="xsd:string"></span><span id='am-762' property="oboInOwl:hasExactSynonym" content="EK3-2" datatype="xsd:string"></span><span id='am-763' property="rdfs:label" content="0998/12" datatype="xsd:string"></span><span id='am-764' property="oboInOwl:hasExactSynonym" content="Ets protein Pointed P2" datatype="xsd:string"></span><span id='am-765' property="rdfs:label" content="l(3)j1B7" datatype="xsd:string"></span><span id='am-766' property="oboInOwl:hasExactSynonym" content="ETS-like protein pointed, isoform P2/D" datatype="xsd:string"></span><span id='am-767' property="oboInOwl:hasExactSynonym" content="POINT" datatype="xsd:string"></span><span id='am-768' property="rdfs:label" content="ptd" datatype="xsd:string"></span><span id='am-769' property="oboInOwl:hasExactSynonym" content="Ets58AB" datatype="xsd:string"></span><span id='am-770' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-771' property="oboInOwl:hasExactSynonym" content="EY3-1" datatype="xsd:string"></span><span id='am-772' property="oboInOwl:hasExactSynonym" content="D-Ets-2" datatype="xsd:string"></span>point</span> used experiments     significantly reduced infections mice. Vaara Porro (25), results spacing           (RXR)4XB-AcpP PMO reduced levels bacteremia cationic nonpolar residues does effect support       dose-dependent manner, (RX)6B-AcpP PMO  suggestion motif cationic-nonpolar-cationic        duced CFU/ml blood similar extents 100  65533;? 65533;g residues slightly effective motifs        300  65533;? 65533;g dose. response treatment tested.                                                              (RFR)4XB-AcpP PMO proportional dose early <br />    mechanisms amphipathic peptides penetrate            times treatment, reflected rate biological membranes controversial depend             survival. (RXR)4XB-AcpP PMO potent structures compositions peptides target               PPMOs tested, 100% mice survived treat- <br /> membranes (12, 29). experiments di-              ment dose low 30  65533;? 65533;g (1.5 mg/kg). <br /> rectly address mechanism penetration, results            (RXR)4XB-AcpP PMO potent ampi- <br /> consistent presented reports demon-         cillin. vitro MIC analysis showed molar basis, <br /> strate importance number repeating sequence            PPMO times potent. motifs choice cationic nonpolar amino acids.       molecular weight (RXR)4XB-AcpP PMO 16 recent study, number RW sequence repeats varied         times greater ampicillin, basis weight, (15). optimal number            (RXR)4XB-AcpP PMO times potent  results RFF repeats        vitro.  mouse model infection used ineffective RFF repeats significantly          experiments, (RXR)4XB-AcpP PMO po- <br /> creased efficacy.  RX repeats inef-         tent, weight basis. Clearly, 30  65533;? 65533;g fective, RX repeats highly effective. similar         (RXR)4XB-AcpP PMO effective lowering <br /> effect shown uptake PPMOs HeLa              CFU/ml blood promoting survival 30  65533;? 65533;g cells (27). suggests length overall   ampicillin (compare Fig. 1A B Fig. 1C D). charge peptide important number         conclude (RXR)4XB-AcpP PMO potent repeats. Alternatively, effect influenced       ampicillin reducing CFU/ml blood increasing <br /> bulkiness hydrophobicity nonpolar chains.          rate survival, model infection cause 6-aminohexanoic acid chain, presumed           used testing. <br /> interaction hydrophobic core bilayer             (RFR)4XB-AcpP PMO lowest MIC, quite different phenylalanine. Previous results         effective PPMO vivo. reason concluded short membrane-penetrating peptides          unclear, possibility composition  <br />  ones used), composition amino        peat pattern natural amino acids suscep- <br /> acids important order amino acids            tible proteolysis animals. Alternatively, (19, 20).                                                            favorable pharmacokinetics bioavailability    results vitro testing showed             PPMOs. <br />  VOL. 53, 2009                                                                                         ANTISENSE MORPHOLINO POTENCY                              529 <br />  <br />  <br />    Thirty percent mice treated 300  65533;? 65533;g/dose (RX)6B-                     3. Brown, K. L., R. E. W. Hancock. 2006. Cationic host defense (antimi- <br />                                                                                       crobial) peptides. Curr. Opin. Immunol. 18:24 8211;30. <br /> AcpP PMO died, despite having levels bacteria blood                      4. Clinical Laboratory Standards Institute. 2006. Methods dilution <br /> comparable blood mice treated 100                             antimicrobial susceptibility tests bacteria grow aerobically, 7th ed., <br />  65533;? 65533;g/dose, survived. results suggest                        approved standard M7-A7. Clinical Laboratory Standards Institute, <br />                                                                                       Wayne, PA. <br /> (RX)6B-AcpP PMO toxic mice 300- 65533;? 65533;g/dose                            5. Deere, J., P. Iversen, B. L. Geller. 2005. Antisense phosphorodiami- <br /> ( 11011;15 mg/kg), account lack ability                          <span id='am-400' about='oboInOwl:date' typeof='owl:Thing'>date</span> morpholino oligomer length target position effects gene- reduce CFU/ml blood compared numbers                            specific inhibition Escherichia coli. Antimicrob. Agents Chemother. <br />                                                                                       49:249 8211;255. group treated 100  65533;? 65533;g/dose. Similar PPMOs                      6. Dennison, S. R., J. Wallace, F. Harris, D.  Phoenix. 2005. Amphiphilic <br /> RX repeating motif toxic tissue culture (27).                          65533;? 65533;-helical antimicrobial peptides structure/function relationships. <br />                                                                                       Protein Pept. Lett. 12:31 8211;39. <br /> apparent toxicity mice likely caused peptide moiety                   7. Geller, B. L., J. D. Deere, D.  Stein, D. Kroeker, H. M. Moulton, P. L. conjugate, PMO attached pep-                            Iversen. 2003. Inhibition gene expression Escherichia coli antisense <br /> tide nontoxic doses (8).                                                  phosphorodiamidate morpholino oligomers. Antimicrob. Agents Che- <br />                                                                                       mother. 47:3233 8211;3239. <br />    (RX)6B-AcpP PMO toxic 15 mg/kg, <span id='am-401' about='obo:IMR_0704199' typeof='owl:Thing'><span id='am-402' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-403' property="oboInOwl:hasExactSynonym" content="Nuclear factor NF-kappa-B p65 subunit" datatype="xsd:string"></span><span id='am-404' property="rdfs:label" content="MGC131774" datatype="xsd:string"></span><span id='am-405' property="rdfs:label" content="NFKB3" datatype="xsd:string"></span><span id='am-406' property="oboInOwl:hasExactSynonym" content="v-rel reticuloendotheliosis viral oncogene homolog A (avian)" datatype="xsd:string"></span><span id='am-407' property="rdfs:label" content="v-rel reticuloendotheliosis viral oncogene homolog A (avian)" datatype="xsd:string"></span><span id='am-408' property="rdfs:label" content="p65" datatype="xsd:string"></span><span id='am-409' property="oboInOwl:hasExactSynonym" content="MGC131774" datatype="xsd:string"></span><span id='am-410' property="oboInOwl:hasDbXref" content="UniProt:Q04206" datatype="xsd:string"></span><span id='am-411' property="rdfs:label" content="Nuclear factor NF-kappa-B p65 subunit" datatype="xsd:string"></span><span id='am-412' property="oboInOwl:hasExactSynonym" content="NUCLEAR FACTOR OF KAPPA LIGHT CHAIN GENE ENHANCER IN B CELLS 3" datatype="xsd:string"></span><span id='am-413' property="rdfs:label" content="RELA" datatype="xsd:string"></span><span id='am-414' property="oboInOwl:hasExactSynonym" content="TRANSCRIPTION FACTOR NFKB3" datatype="xsd:string"></span><span id='am-415' property="oboInOwl:hasExactSynonym" content="Transcription factor p65" datatype="xsd:string"></span><span id='am-416' property="oboInOwl:hasExactSynonym" content="NFKB3" datatype="xsd:string"></span><span id='am-417' property="rdfs:label" content="Nuclear factor of kappa light polypeptide gene enhancer in B-cells 3" datatype="xsd:string"></span><span id='am-418' property="oboInOwl:hasExactSynonym" content="RELA" datatype="xsd:string"></span><span id='am-419' property="rdfs:label" content="V-REL AVIAN RETICULOENDOTHELIOSIS VIRAL ONCOGENE HOMOLOG A" datatype="xsd:string"></span><span id='am-420' property="rdfs:label" content="NUCLEAR FACTOR KAPPA-B, SUBUNIT 3" datatype="xsd:string"></span><span id='am-421' property="oboInOwl:id" content="IMR:0704199" datatype="xsd:string"></span><span id='am-422' property="rdfs:label" content="Transcription factor p65" datatype="xsd:string"></span><span id='am-423' property="rdfs:label" content="NFKB, p65 SUBUNIT" datatype="xsd:string"></span><span id='am-424' property="rdfs:label" content="TRANSCRIPTION FACTOR NFKB3" datatype="xsd:string"></span><span id='am-425' property="rdfs:label" content="TF65_HUMAN" datatype="xsd:string"></span><span id='am-426' property="rdfs:label" content="NUCLEAR FACTOR OF KAPPA LIGHT CHAIN GENE ENHANCER IN B CELLS 3" datatype="xsd:string"></span><span id='am-427' property="oboInOwl:hasExactSynonym" content="NFKB, p65 SUBUNIT" datatype="xsd:string"></span><span id='am-428' property="oboInOwl:hasExactSynonym" content="p65" datatype="xsd:string"></span><span id='am-429' property="oboInOwl:hasExactSynonym" content="NUCLEAR FACTOR KAPPA-B, SUBUNIT 3" datatype="xsd:string"></span><span id='am-430' property="oboInOwl:hasExactSynonym" content="V-REL AVIAN RETICULOENDOTHELIOSIS VIRAL ONCOGENE HOMOLOG A" datatype="xsd:string"></span><span id='am-431' property="oboInOwl:hasExactSynonym" content="Nuclear factor of kappa light polypeptide gene enhancer in B-cells 3" datatype="xsd:string"></span>rela</span>-                         8. Geller, B. L., J. Deere, L. Tilley, P. L. Iversen. 2005. Antisense phos- <br /> tively short time death (12 h) bit unusual suggests                     phorodiamidate morpholino oligomer inhibits viability Escherichia coli rapid event lipopolysaccharide-induced <span id='am-266' about='obo:IMR_0000006' typeof='owl:Thing obo:IMR_0000949 obo:IMR_0000002 obo:IMR_0000001'><span id='am-267' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-268' property="oboInOwl:hasDbXref" content="GO:0005125" datatype="xsd:string"></span><span id='am-269' property="rdfs:label" content="cytokine" datatype="xsd:string"></span><span id='am-270' property="obo:IAO_0000115" content="Extracellular signal protein or peptide that acts as a local mediator in cell-cell communication." datatype="xsd:string"></span><span id='am-271' property="oboInOwl:id" content="IMR:0000006" datatype="xsd:string"></span>cytokine</span> <span id='am-89' about='obo:IMR_0000355' typeof='owl:Thing obo:IMR_0000345 obo:IMR_0000949 obo:IMR_0000354 obo:IMR_0000001 obo:IMR_0000333'><span id='am-90' property="oboInOwl:hasExactSynonym" content="p130 Crk associated substrate" datatype="xsd:string"></span><span id='am-91' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-92' property="rdfs:label" content="Cas" datatype="xsd:string"></span><span id='am-93' property="oboInOwl:id" content="IMR:0000355" datatype="xsd:string"></span><span id='am-94' property="rdfs:label" content="p130 Crk associated substrate" datatype="xsd:string"></span><span id='am-95' property="oboInOwl:hasExactSynonym" content="Cas" datatype="xsd:string"></span><span id='am-96' property="rdfs:label" content="p130Cas" datatype="xsd:string"></span>cas</span>-                        pure culture mouse peritonitis. J. Antimicrob. Chemother. 55:983 8211; <br />                                                                                       988. <br /> cade. Alternatively, plausible arginines (RX)6                   9. Good, L., P. E. Nielsen. 1998. Inhibition translation bacterial converted <span id='am-389' about='obo:IMR_0002004' typeof='owl:Thing obo:IMR_0000949 obo:IMR_0000001 obo:IMR_0000207 obo:IMR_0000952'><span id='am-390' property="rdfs:label" content="nitric oxide synthase" datatype="xsd:string"></span><span id='am-391' property="oboInOwl:hasDbXref" content="GO:0004517" datatype="xsd:string"></span><span id='am-392' property="oboInOwl:hasDbXref" content="EC:1.14.13.39" datatype="xsd:string"></span><span id='am-393' property="oboInOwl:id" content="IMR:0002004" datatype="xsd:string"></span><span id='am-394' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>nitric oxide synthase</span>.                         growth peptide nucleic acid targeted ribosomal RNA. <span id='am-432' about='obo:IMR_0010425' typeof='owl:Thing obo:IMR_0000949 obo:IMR_0010045 obo:IMR_0000001 obo:IMR_0000207 obo:IMR_0000952'><span id='am-433' property="rdfs:label" content="P5C reductase" datatype="xsd:string"></span><span id='am-434' property="oboInOwl:id" content="IMR:0010425" datatype="xsd:string"></span><span id='am-435' property="oboInOwl:hasExactSynonym" content="PROC" datatype="xsd:string"></span><span id='am-436' property="rdfs:label" content="pyrroline-5-carboxylate reductase monomer" datatype="xsd:string"></span><span id='am-437' property="oboInOwl:hasExactSynonym" content="pyrroline-5-carboxylate reductase monomer" datatype="xsd:string"></span><span id='am-438' property="oboInOwl:hasExactSynonym" content="P5CR" datatype="xsd:string"></span><span id='am-439' property="oboInOwl:hasDbXref" content="EC:1.5.1.2" datatype="xsd:string"></span><span id='am-440' property="rdfs:label" content="PROC" datatype="xsd:string"></span><span id='am-441' property="oboInOwl:hasExactSynonym" content="P5C reductase" datatype="xsd:string"></span><span id='am-442' property="rdfs:label" content="P5CR" datatype="xsd:string"></span><span id='am-443' property="rdfs:label" content="Pyrroline-5-carboxylate reductase" datatype="xsd:string"></span><span id='am-444' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>Proc</span>. Natl. Acad. <br />                                                                                       Sci. USA 95:2073 8211;2076. <br /> lead critical events lung, heart, <span id='am-1' about='obo:IMR_0700475' typeof='owl:Thing'><span id='am-2' property="rdfs:label" content="Spectrin alpha chain, brain" datatype="xsd:string"></span><span id='am-3' property="rdfs:label" content="SPTA2_MOUSE" datatype="xsd:string"></span><span id='am-4' property="rdfs:label" content="spectrin alpha 2" datatype="xsd:string"></span><span id='am-5' property="oboInOwl:hasExactSynonym" content="Sptan1" datatype="xsd:string"></span><span id='am-6' property="rdfs:label" content="Spectrin, non-erythroid alpha chain" datatype="xsd:string"></span><span id='am-7' property="oboInOwl:hasExactSynonym" content="Fodrin alpha chain" datatype="xsd:string"></span><span id='am-8' property="oboInOwl:hasExactSynonym" content="Spta2" datatype="xsd:string"></span><span id='am-9' property="rdfs:label" content="alpha-fodrin" datatype="xsd:string"></span><span id='am-10' property="oboInOwl:hasExactSynonym" content="spectrin alpha 2" datatype="xsd:string"></span><span id='am-11' property="oboInOwl:hasExactSynonym" content="Alpha-II spectrin" datatype="xsd:string"></span><span id='am-12' property="rdfs:label" content="Spna2" datatype="xsd:string"></span><span id='am-13' property="oboInOwl:id" content="IMR:0700475" datatype="xsd:string"></span><span id='am-14' property="rdfs:label" content="Alpha-II spectrin" datatype="xsd:string"></span><span id='am-15' property="oboInOwl:hasExactSynonym" content="Spna2" datatype="xsd:string"></span><span id='am-16' property="oboInOwl:hasDbXref" content="UniProt:P16546" datatype="xsd:string"></span><span id='am-17' property="oboInOwl:hasExactSynonym" content="alpha-fodrin" datatype="xsd:string"></span><span id='am-18' property="rdfs:label" content="Fodrin alpha chain" datatype="xsd:string"></span><span id='am-19' property="oboInOwl:hasExactSynonym" content="Spectrin alpha chain, brain" datatype="xsd:string"></span><span id='am-20' property="rdfs:label" content="brain" datatype="xsd:string"></span><span id='am-21' property="oboInOwl:hasExactSynonym" content="Spna-2" datatype="xsd:string"></span><span id='am-22' property="oboInOwl:hasExactSynonym" content="Spectrin, non-erythroid alpha chain" datatype="xsd:string"></span><span id='am-23' property="rdfs:label" content="Spta2" datatype="xsd:string"></span><span id='am-24' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-25' property="oboInOwl:hasExactSynonym" content="brain" datatype="xsd:string"></span><span id='am-26' property="rdfs:label" content="Spna-2" datatype="xsd:string"></span><span id='am-27' property="rdfs:label" content="Sptan1" datatype="xsd:string"></span>brain</span>,                                                                                   10. Good, L., S. K. Awasthi, R. Dryselius, O. Larsson, P. E. Nielsen. 2001. lead death 12 h.                                                          Bacterial antisense effects peptide-PNA conjugates. <span id='am-136' about='obo:IMR_0701753' typeof='owl:Thing'><span id='am-137' property="rdfs:label" content="Voltage-gated sodium channel subunit alpha Nav1.9" datatype="xsd:string"></span><span id='am-138' property="oboInOwl:hasExactSynonym" content="Sensory neuron sodium channel 2" datatype="xsd:string"></span><span id='am-139' property="rdfs:label" content="NSS2" datatype="xsd:string"></span><span id='am-140' property="oboInOwl:hasExactSynonym" content="NaT" datatype="xsd:string"></span><span id='am-141' property="rdfs:label" content="Scn11a" datatype="xsd:string"></span><span id='am-142' property="oboInOwl:hasExactSynonym" content="Voltage-gated sodium channel subunit alpha Nav1.9" datatype="xsd:string"></span><span id='am-143' property="rdfs:label" content="Sensory neuron sodium channel 2" datatype="xsd:string"></span><span id='am-144' property="oboInOwl:hasExactSynonym" content="Nat" datatype="xsd:string"></span><span id='am-145' property="rdfs:label" content="Sns2" datatype="xsd:string"></span><span id='am-146' property="oboInOwl:hasExactSynonym" content="NaN" datatype="xsd:string"></span><span id='am-147' property="rdfs:label" content="Nan" datatype="xsd:string"></span><span id='am-148' property="oboInOwl:hasExactSynonym" content="Sns2" datatype="xsd:string"></span><span id='am-149' property="oboInOwl:hasExactSynonym" content="Sodium channel protein type 11 subunit alpha" datatype="xsd:string"></span><span id='am-150' property="rdfs:label" content="SCNBA_MOUSE" datatype="xsd:string"></span><span id='am-151' property="oboInOwl:hasExactSynonym" content="Nan" datatype="xsd:string"></span><span id='am-152' property="rdfs:label" content="Sodium channel protein type XI subunit alpha" datatype="xsd:string"></span><span id='am-153' property="oboInOwl:hasExactSynonym" content="Scn11a" datatype="xsd:string"></span><span id='am-154' property="rdfs:label" content="Sodium channel protein type 11 subunit alpha" datatype="xsd:string"></span><span id='am-155' property="rdfs:label" content="NaN" datatype="xsd:string"></span><span id='am-156' property="rdfs:label" content="Nat" datatype="xsd:string"></span><span id='am-157' property="rdfs:label" content="sodium channel, voltage-gated, type XI, alpha" datatype="xsd:string"></span><span id='am-158' property="oboInOwl:hasExactSynonym" content="NSS2" datatype="xsd:string"></span><span id='am-159' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-160' property="oboInOwl:hasExactSynonym" content="Sodium channel protein type XI subunit alpha" datatype="xsd:string"></span><span id='am-161' property="oboInOwl:hasExactSynonym" content="SNS2" datatype="xsd:string"></span><span id='am-162' property="oboInOwl:id" content="IMR:0701753" datatype="xsd:string"></span><span id='am-163' property="oboInOwl:hasDbXref" content="UniProt:Q9R053" datatype="xsd:string"></span><span id='am-164' property="oboInOwl:hasExactSynonym" content="sodium channel, voltage-gated, type XI, alpha" datatype="xsd:string"></span><span id='am-165' property="rdfs:label" content="SNS2" datatype="xsd:string"></span><span id='am-166' property="rdfs:label" content="NaT" datatype="xsd:string"></span>Nat</span>. Biotechnol. 19: <br />    apparent short-term, gross toxicity                          360 8211;364. <br />                                                                                   11. Gruegelsiepe, H., O. Brandt, R. K. Hartmann. 2006. Antisense inhibi- <br /> (RXR)4XB-AcpP PMO, highest dose tested (300                               tion RNase P: mechanistic aspects application live bacteria. J. Biol. <br />  65533;? 65533;g [15 mg/kg]), determined 100% survival rate                            Chem. 281:30613 8211;30620. <br /> mice treatment group. Previous results shown                    12. Henriques, S. T., M. N. Melo, M.  R. B. Castanho. 2006. Cell-pene- <br />                                                                                       trating peptides antimicrobial peptides: different  Bio- (RXR)4XB PMO causes significant toxicity 150 mg/kg                            chem. J. 399:1 8211;7. <br /> rats 50% lethal dose 210 mg/kg (2).                   13. Kulyte, , N. Nekhotiaeva, S. K. Awasthi, L. Good. 2005. Inhibition safety values converted mice use                           Mycobacterium smegmatis gene expression growth using antisense pep- <br />                                                                                       tide nucleic acids. J. Mol. Microbiol. Biotechnol. 9:101 8211;109. <br /> conventional surface area calculations (24), toxicity mice                 14. Kurupati, P., K. S. W. Tan, G. Kumarasinghe, C. L. <span id='am-551' about='obo:IMR_0704091' typeof='owl:Thing'><span id='am-552' property="rdfs:label" content="MGC33735" datatype="xsd:string"></span><span id='am-553' property="oboInOwl:hasDbXref" content="UniProt:P63092" datatype="xsd:string"></span><span id='am-554' property="rdfs:label" content="NESP55" datatype="xsd:string"></span><span id='am-555' property="oboInOwl:hasExactSynonym" content="GNAS" datatype="xsd:string"></span><span id='am-556' property="oboInOwl:hasExactSynonym" content="GNASXL" datatype="xsd:string"></span><span id='am-557' property="rdfs:label" content="C20orf45" datatype="xsd:string"></span><span id='am-558' property="oboInOwl:hasExactSynonym" content="NESP55" datatype="xsd:string"></span><span id='am-559' property="oboInOwl:hasExactSynonym" content="C20orf45" datatype="xsd:string"></span><span id='am-560' property="rdfs:label" content="POH" datatype="xsd:string"></span><span id='am-561' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-562' property="rdfs:label" content="GNAS1" datatype="xsd:string"></span><span id='am-563' property="oboInOwl:hasExactSynonym" content="MGC33735" datatype="xsd:string"></span><span id='am-564' property="oboInOwl:hasExactSynonym" content="PHP1C" datatype="xsd:string"></span><span id='am-565' property="rdfs:label" content="AHO" datatype="xsd:string"></span><span id='am-566' property="oboInOwl:hasExactSynonym" content="PHP1B" datatype="xsd:string"></span><span id='am-567' property="rdfs:label" content="NESP" datatype="xsd:string"></span><span id='am-568' property="oboInOwl:hasExactSynonym" content="GNAS complex locus" datatype="xsd:string"></span><span id='am-569' property="oboInOwl:hasExactSynonym" content="GPSA" datatype="xsd:string"></span><span id='am-570' property="rdfs:label" content="GSP" datatype="xsd:string"></span><span id='am-571' property="oboInOwl:hasExactSynonym" content="GSA" datatype="xsd:string"></span><span id='am-572' property="rdfs:label" content="SCG6" datatype="xsd:string"></span><span id='am-573' property="oboInOwl:hasExactSynonym" content="GNAS1" datatype="xsd:string"></span><span id='am-574' property="rdfs:label" content="GSA" datatype="xsd:string"></span><span id='am-575' property="oboInOwl:id" content="IMR:0704091" datatype="xsd:string"></span><span id='am-576' property="rdfs:label" content="PHP1A" datatype="xsd:string"></span><span id='am-577' property="rdfs:label" content="GNAS" datatype="xsd:string"></span><span id='am-578' property="oboInOwl:hasExactSynonym" content="Guanine nucleotide-binding protein G(s) subunit alpha isoforms short" datatype="xsd:string"></span><span id='am-579' property="oboInOwl:hasExactSynonym" content="GSP" datatype="xsd:string"></span><span id='am-580' property="rdfs:label" content="GNAS2_HUMAN" datatype="xsd:string"></span><span id='am-581' property="rdfs:label" content="PHP1B" datatype="xsd:string"></span><span id='am-582' property="oboInOwl:hasExactSynonym" content="AHO" datatype="xsd:string"></span><span id='am-583' property="oboInOwl:hasExactSynonym" content="POH" datatype="xsd:string"></span><span id='am-584' property="oboInOwl:hasExactSynonym" content="NESP" datatype="xsd:string"></span><span id='am-585' property="rdfs:label" content="GNASXL" datatype="xsd:string"></span><span id='am-586' property="rdfs:label" content="Guanine nucleotide-binding protein G(s) subunit alpha isoforms short" datatype="xsd:string"></span><span id='am-587' property="rdfs:label" content="GNAS complex locus" datatype="xsd:string"></span><span id='am-588' property="rdfs:label" content="GPSA" datatype="xsd:string"></span><span id='am-589' property="rdfs:label" content="Adenylate cyclase-stimulating G alpha protein" datatype="xsd:string"></span><span id='am-590' property="oboInOwl:hasExactSynonym" content="Adenylate cyclase-stimulating G alpha protein" datatype="xsd:string"></span><span id='am-591' property="rdfs:label" content="PHP1C" datatype="xsd:string"></span><span id='am-592' property="oboInOwl:hasExactSynonym" content="SCG6" datatype="xsd:string"></span><span id='am-593' property="oboInOwl:hasExactSynonym" content="PHP1A" datatype="xsd:string"></span>Poh</span>. 2007. Inhibi- translate 300 mg/kg.  estimated ther-                         tion gene expression growth antisense peptide nucleic acids                                                                                       multiresistant  65533;? 65533;-lactamase-producing Klebsiella pneumonia strain. Antimi- <br /> apeutic index (50% lethal dose/50% effective dose)                             crob. Agents Chemother. 51:805 8211;811. <br /> (RXR)4XB-AcpP PMO greater 200 (300 mg/kg/                             15. Liu, ,  Brady,  Young, B. Rasimick, K. Chen, C. Zhou, N. R. <br /> 1.5 mg/kg).                                                                           Kallenbach. 2007. Length effects antimicrobial peptides (RW)n <br />                                                                                       series. Antimicrob. Agents Chemother. 51:597 8211;603. <br />    Recently, (RXR)4 efficiently deliver                         16. Maloy, W. L., U. P. Kari. 1995. Structure-activity studies magainins <br /> PMOs eukaryotic cell plasma membrane                                 host defense peptides. Biopolymers 37:105 8211;122. <br /> HeLa CHO cells (1). mechanism entry                            17. Nekhotiaeva, N., S. K. Awasthi, P. E. Nielsen, L. Good. 2004. Inhibition <br />                                                                                       Staphylococcus aureus gene expression growth using antisense peptide eukaryotic cell plasma membrane apparently                              nucleic acids. Mol. Ther. 10:252 8211;259. <br /> mediated binding <span id='am-698' about='obo:IMR_0000552' typeof='owl:Thing obo:IMR_0000949 obo:IMR_0000540 obo:IMR_0000001 obo:IMR_0000950'><span id='am-699' property="rdfs:label" content="proteoglycan" datatype="xsd:string"></span><span id='am-700' property="obo:IAO_0000115" content="Proteoglycans are a diverse family of molecules characterized by a core protein to which is attached one or more glycosaminoglycan (GAG) side-chains." datatype="xsd:string"></span><span id='am-701' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-702' property="oboInOwl:id" content="IMR:0000552" datatype="xsd:string"></span>proteoglycan</span>, mechanism sub-                        18. Shafer, W. M., F. Hubalek, M. Huang, J. Pohl. 1996. Bactericidal <br />                                                                                       activity synthetic peptide (<span id='am-594' about='obo:IMR_0100106' typeof='owl:Thing obo:IMR_0000949 obo:IMR_0000002 obo:IMR_0100046 obo:IMR_0000001 obo:IMR_0100086 obo:IMR_0100087'><span id='am-595' property="rdfs:label" content="chorionic gonadotropin" datatype="xsd:string"></span><span id='am-596' property="obo:IAO_0000115" content="A gonadotropic glycoprotein hormone produced primarily by the PLACENTA. Similar to the pituitary LUTEINIZING HORMONE in structure and function, chorionic gonadotropin is involved in maintaining the CORPUS LUTEUM during pregnancy. CG consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is virtually identical to the three pituitary glycoprotein hormones (TSH, LH, and FSH), but the beta subunit is unique and confers its biological specificity." datatype="xsd:string"></span><span id='am-597' property="oboInOwl:hasDbXref" content="MeSH:D006063" datatype="xsd:string"></span><span id='am-598' property="oboInOwl:id" content="IMR:0100106" datatype="xsd:string"></span><span id='am-599' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-600' property="oboInOwl:hasExactSynonym" content="CG" datatype="xsd:string"></span><span id='am-601' property="rdfs:label" content="CG" datatype="xsd:string"></span>CG</span> 117-136) human lysosomal cathep- <br /> sequent transit internal membranes nu-                            <span id='am-445' about='obo:IMR_0703090' typeof='owl:Thing'><span id='am-446' property="rdfs:label" content="SIN" datatype="xsd:string"></span><span id='am-447' property="oboInOwl:hasExactSynonym" content="KIAA1452" datatype="xsd:string"></span><span id='am-448' property="oboInOwl:hasExactSynonym" content="RPC5" datatype="xsd:string"></span><span id='am-449' property="rdfs:label" content="RNA polymerase III subunit C5" datatype="xsd:string"></span><span id='am-450' property="oboInOwl:hasExactSynonym" content="FLJ10509" datatype="xsd:string"></span><span id='am-451' property="rdfs:label" content="DNA-directed RNA polymerase III subunit RPC5" datatype="xsd:string"></span><span id='am-452' property="rdfs:label" content="POLR3E" datatype="xsd:string"></span><span id='am-453' property="rdfs:label" content="KIAA1452" datatype="xsd:string"></span><span id='am-454' property="rdfs:label" content="FLJ10509" datatype="xsd:string"></span><span id='am-455' property="oboInOwl:hasDbXref" content="UniProt:Q9NVU0" datatype="xsd:string"></span><span id='am-456' property="oboInOwl:hasExactSynonym" content="polymerase (RNA) III (DNA directed) polypeptide E (80kD)" datatype="xsd:string"></span><span id='am-457' property="oboInOwl:hasExactSynonym" content="SIN" datatype="xsd:string"></span><span id='am-458' property="rdfs:label" content="RPC5_HUMAN" datatype="xsd:string"></span><span id='am-459' property="oboInOwl:hasExactSynonym" content="RNA polymerase III subunit C5" datatype="xsd:string"></span><span id='am-460' property="rdfs:label" content="RPC5" datatype="xsd:string"></span><span id='am-461' property="oboInOwl:hasExactSynonym" content="DNA-directed RNA polymerase III subunit RPC5" datatype="xsd:string"></span><span id='am-462' property="rdfs:label" content="polymerase (RNA) III (DNA directed) polypeptide E (80kD)" datatype="xsd:string"></span><span id='am-463' property="rdfs:label" content="DNA-directed RNA polymerase III 80 kDa polypeptide" datatype="xsd:string"></span><span id='am-464' property="oboInOwl:hasExactSynonym" content="DNA-directed RNA polymerase III 80 kDa polypeptide" datatype="xsd:string"></span><span id='am-465' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-466' property="oboInOwl:hasExactSynonym" content="POLR3E" datatype="xsd:string"></span><span id='am-467' property="oboInOwl:id" content="IMR:0703090" datatype="xsd:string"></span>sin</span> G dependent arginine content. Infect. Immun. 64:4842 8211;4845. <br /> cleus unknown. ability (RXR)4XB mediate                          19. Strom, M. B., B. E. Haug, O. Rekdal, M. L. Skar, W. Stensen, J. S. <br /> entry PMOs eukaryotic prokaryotic cells                              Svendsen. 2003. Important structural features 15-residue lactoferricin <br />                                                                                       derivatives methods improvement antimicrobial activity. Biochem. <br /> suggests antibacterial PPMOs designed use                           Cell Biol. 80:65 8211;74. intracellular bacteria.  preliminary data                       20. Strom, M. B., O. Rekdal, J. S. Svendsen. 2002. Antimicrobial activity dicate (RXR)4XB PMOs targeted specific essential                              short arginine- tryptophan-rich peptides. J. Pept. Sci. 8:431 8211;437. <br />                                                                                   21. Tan, X.-X., J. K. Actor, Y. Chen. 2005. Peptide nucleic acid antisense <br /> genes significantly reduce intracellular Salmonella, Chlamydia,                       oligomer therapeutic strategy bacterial infection: proof prin- Mycobacterium levels (G. Mitev B. L. Geller, unpub-                           ciple using mouse intraperitoneal infection. Antimicrob. Agents Chemother. <br /> lished data).                                                                         49:3203 8211;3207. <br />                                                                                   22. Tilley, L. D., B. L. Mellbye, S. E. Puckett, P. L. Iversen, B. L. Geller. <br />                                                                                       2007. Antisense peptide-phosphorodiamidate morpholino oligomer conju- <br />                         ACKNOWLEDGMENTS                                               gate: dose-response mice infected Escherichia coli. J. Antimicrob. <br />                                                                                       Chemother. 59:66 8211;73. <br />   thank entire chemistry department AVI BioPharma                   23. Tilley, L. D., O. S. Hine, J.  Kellogg, J. N. Hassinger, D. D. Weller, P. L. <br /> making purifying PPMOs. thank Alix Gitelman advice                     Iversen, B. L. Geller. 2006. Gene-specific effects antisense phos- statistical analysis.                                                              phorodiamidate morpholino oligomer-peptide conjugates Escherichia <br />   work funded AVI BioPharma.                                              coli Salmonella enterica serovar Typhimurium pure culture   Bruce Geller employed AVI BioPharma Oregon                          tissue culture. Antimicrob. Agents Chemother. 50:2789 8211;2796. <br />                                                                                   24. U.S. Food Drug Administration, Center Drug Evaluation  <br /> State University.                                                                     search. 2008. Dose calculator convert animal dose human equivalent <br />                                                                                       dose. Center Drug Evaluation Research, U.S. Food Drug Ad- <br />                                REFERENCES                                             ministration, Rockville MD. http://www.fda.<span id='am-347' about='obo:IMR_0700676' typeof='owl:Thing'><span id='am-348' property="rdfs:label" content="RAB3D_HUMAN" datatype="xsd:string"></span><span id='am-349' property="oboInOwl:hasExactSynonym" content="RAB3D, member RAS oncogene family" datatype="xsd:string"></span><span id='am-350' property="rdfs:label" content="GLIOBLASTOMA OVEREXPRESSED" datatype="xsd:string"></span><span id='am-351' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-352' property="oboInOwl:hasDbXref" content="UniProt:O95716" datatype="xsd:string"></span><span id='am-353' property="oboInOwl:hasExactSynonym" content="D2-2" datatype="xsd:string"></span><span id='am-354' property="oboInOwl:hasExactSynonym" content="GOV" datatype="xsd:string"></span><span id='am-355' property="oboInOwl:hasExactSynonym" content="RAB3D" datatype="xsd:string"></span><span id='am-356' property="oboInOwl:hasExactSynonym" content="GLIOBLASTOMA OVEREXPRESSED" datatype="xsd:string"></span><span id='am-357' property="rdfs:label" content="GOV" datatype="xsd:string"></span><span id='am-358' property="rdfs:label" content="RAB3D, member RAS oncogene family" datatype="xsd:string"></span><span id='am-359' property="rdfs:label" content="RAD3D" datatype="xsd:string"></span><span id='am-360' property="oboInOwl:hasExactSynonym" content="RAS-ASSOCIATED PROTEIN RAB3D" datatype="xsd:string"></span><span id='am-361' property="oboInOwl:hasExactSynonym" content="RAB16" datatype="xsd:string"></span><span id='am-362' property="oboInOwl:hasExactSynonym" content="Ras-related protein Rab-3D" datatype="xsd:string"></span><span id='am-363' property="oboInOwl:id" content="IMR:0700676" datatype="xsd:string"></span><span id='am-364' property="rdfs:label" content="D2-2" datatype="xsd:string"></span><span id='am-365' property="rdfs:label" content="RAB3D" datatype="xsd:string"></span><span id='am-366' property="rdfs:label" content="RAB16" datatype="xsd:string"></span><span id='am-367' property="rdfs:label" content="Ras-related protein Rab-3D" datatype="xsd:string"></span><span id='am-368' property="rdfs:label" content="RAS-ASSOCIATED PROTEIN RAB3D" datatype="xsd:string"></span><span id='am-369' property="oboInOwl:hasExactSynonym" content="RAD3D" datatype="xsd:string"></span>gov</span>/cder/cancer/animalframe <br /> 1. Abes, S., H. M. Moulton, P. Clair, P. Prevot, D. S. Youngblood, R. P. Wu,          .htm. Date accessed, 7 July 2008. <br />    P. L. Iversen, B. Lebleu. 2006. Vectorization morpholino oli-           25. Vaara, M., M. Porro. 1996. Group peptides act synergistically <br />    gomers (R-Ahx-R)4 peptide allows efficient splicing correction           hydrophobic antibiotics gram-negative enteric bacteria. Antimi- <br />    absence endosomolytic agents. J. Control. Release 116:304 8211;313.              crob. Agents Chemother. 40:1801 8211;1805. <br /> 2. Amantana, , H. M. Moulton, M. L. Cate M.  <br /> </body></html>